RapidBio Inc.

Cloud service for generative AI in early drug discovery focusing on proteins and small molecules. Platforms can be accessed through a web interface or API endpoints and outputs can be visualized and downloaded. AI models can be further fine-tuned and trained on customers’ proprietary data on Cloud. In an era where rapid commercialization is essential, RapidBio agentic technology is set to revolutionize how pharmaceutical companies bring products to market. Designed specifically for the pharmaceutical industry, the platform streamlines complex marketing processes, delivers real-time insights, and enables actionable strategies that help companies optimize their approach, maintain compliance, and enhance patient engagement. We are here to revolutionize human health by reimagining drug discovery and commercialization leveraging the power and speed of Artificial Intelligence.